ITGAM and neoplasm: While nanoparticles are often phagocytosed non-specifically by myeloid cells17, the targeting particles described herein exhibit very modest interaction with CD11b+ immune cells isolated from the blood and tumor 1 and 24 h after intravenous injection (Supplementary Fig. 3c).